                </a></li></ul></div><p><strong>Figure 4.  <span>cFos expression.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>Fear conditioning (FC) increased cFos expression as compared to the NFC group in the anterior cingulate (p = 0.003; A), nucleus accumbens shell (p&lt;0.0001; B), and paraventricular nucleus (p&lt;0.0001; C), anterior basolateral amygdala (p = 0.002; D) and lateral amygdala (p&lt;0.0001; E). Ketamine blocked the effect of fear conditioning (FC vs. FC+Ket) in the anterior cingulate (p&lt;0.0001; A), nucleus accumbens shell (p = 0.002; B), paraventricular nucleus (p&lt;0.0001; C), anterior basolateral amygdala (p = 0.001) and lateral amygdala (p = 0.004). As hypothesized, clozapine was able to counteract the blockade of ketamine on fear conditioning (FC+Ket vs. FC+Ket+Cloz) in the anterior cingulate (p&lt;0.0001), nucleus accumbens shell (p = 0.001), paraventricular nucleus (p = 0.001), anterior basolateral amygdala (p&lt;0.0001) and lateral amygdala (p&lt;0.0001). A slight restoration by haloperidol was noted in the anterior cingulate (p = 0.042). <em>Cloz, clozapine; FC, fear conditioning; Halo, haloperidol; Ket, Ketamine; LY, LY 379278; NFC, no fear conditioning.</em></p>
